Larson Financial Group’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $227 | Buy |
2
+1
| +100% | +$114 | ﹤0.01% | 3012 |
|
|
2025
Q1 | $105 | Hold |
1
| – | – | ﹤0.01% | 2883 |
|
|
2024
Q4 | $107 | Hold |
1
| – | – | ﹤0.01% | 2575 |
|
|
2024
Q3 | $100 | Hold |
1
| – | – | ﹤0.01% | 2520 |
|
|
2024
Q2 | $84 | Buy |
+1
| New | +$84 | ﹤0.01% | 2274 |
|
|
2024
Q1 | – | Sell |
-20
| Closed | -$1.43K | – | 1856 |
|
|
2023
Q4 | $1.43K | Buy |
+20
| New | +$1.43K | ﹤0.01% | 1408 |
|